{"product_id":"iaslc-thoracic-oncology-hardback-9780323523578","title":"IASLC Thoracic Oncology (Hardback) 9780323523578","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eIASLC Thoracic Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eComprehensive, multidisciplinary guidance on lung cancer from experts worldwide.\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eHarvey Pass (Author), David Ball (Author), Giorgio Scagliotti (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323523578, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 23 June 2017\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e704 pages, 530 illustrations (530 in full color)\u003cbr\u003e27.6 x 21.5 x 3.7 cm, 1.95 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"Overall, this is an outstanding resource that everyone interested in this subject must have…. The main objective of this book and the well-thought-out content sets it apart from any other book in the same space.\"\u003c\/i\u003e \u003cb\u003eReviewed by\u003c\/b\u003e Ravi Salgia, MD, PhD (City of Hope) \u003cb\u003eDoody's Score: 98, 5 Stars!\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eGlobal experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with \u003cb\u003etoday’s best approaches to lung cancer diagnosis, treatment, and follow-up\u003c\/b\u003e. \u003ci\u003eIASLC Thoracic Oncology, 2nd Edition,\u003c\/i\u003e keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. \u003cb\u003eWritten in a straightforward, practical style for the busy clinician,\u003c\/b\u003e this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eOffers \u003cb\u003epractical, relevant coverage\u003c\/b\u003e of basic science, epidemiology, pulmonology, medical and radiation oncology, surgery, pathology, palliative care, nursing, and advocacy.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides \u003cb\u003eauthoritative guidance from the IASLC\u003c\/b\u003e – the only global organization dedicated to the study of lung cancer.\u003c\/li\u003e \u003c\/ul\u003e\n\u003cul\u003e \u003cli\u003eIncludes \u003cb\u003enew content\u003c\/b\u003e on molecular testing, immunotherapy, early detection, staging and the IASLC staging system, surgical resection for stage I and stage II lung cancer, and stem cells in lung cancer.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures a \u003cb\u003enew full-color design\u003c\/b\u003e throughout, as well as \u003cb\u003eupdated diagnostic algorithms\u003c\/b\u003e.\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eExpert Consult™ eBook version included with purchase. This \u003cb\u003eenhanced eBook experience\u003c\/b\u003e allows you to search all of the text, figures, Q\u0026amp;As, and references from the book on a variety of devices.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eSection 1: Lung Cancer Control and Epidemiology\u003c\/p\u003e \u003cp\u003e1. Classical Epidemiology\u003c\/p\u003e \u003cp\u003e2. Tobacco Control and Primary Prevention\u003c\/p\u003e \u003cp\u003e3. Tobacco Cessation \u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4. Non-Smoking Related Lung Cancer\u003c\/p\u003e \u003cp\u003e5. Gender-Related Differences in Lung Cancer\u003c\/p\u003e \u003cp\u003e6. Genetic Susceptibility to Lung Cancer\u003c\/p\u003e \u003cp\u003e7. Early Detection and Radiologic Screening\u003c\/p\u003e \u003cp\u003e8. Preclinical Biomarkers for The Early Detection of Lung Cancer\u003c\/p\u003e \u003cp\u003e9. Chemoprevention of Lung Cancer: Present and Developing Technologies\u003c\/p\u003e \u003cp\u003eSection 2: Lung Cancer Molecular Carcinogenesis\u003c\/p\u003e \u003cp\u003e10. Copy Number Abnormalities and Gene Rearrangements in Lung Cancer: Present and Developing Technologies\u003c\/p\u003e \u003cp\u003e11. Mutational Events in Lung Cancer: Present and Developing Technologies\u003c\/p\u003e \u003cp\u003e12. Epigenetic Events, Alterations, and Remodeling in Lung Cancer: Present and Developing Technologies\u003c\/p\u003e \u003cp\u003e13. Stem Cells and Lung Cancer: In Vitro and In Vivo Studies\u003c\/p\u003e \u003cp\u003e14. Microenvironment and Lung Cancer\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15. MicroRNAs as Biomarkers for Lung Cancer\u003c\/p\u003e \u003cp\u003eSection 3: Immunology\u003c\/p\u003e \u003cp\u003e16. Humoral and Cellular Immune Dysregulation and Lung Cancer\u003c\/p\u003e \u003cp\u003eSection 4: Pathology\u003c\/p\u003e \u003cp\u003e17. Classic Anatomic Pathology and Lung Cancer\u003c\/p\u003e \u003cp\u003e18. Molecular Testing and Lung Cancer\u003c\/p\u003e \u003cp\u003e19. Management of the Small Biopsy in the Molecular Er\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eSection 5: Clinical and Radiologic Presentation of Lung Cancer\u003c\/p\u003e \u003cp\u003e20. Clinical Presentation\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21. Conventional Imaging Lung Cancer\u003c\/p\u003e \u003cp\u003e22. PET Imaging of Lung Cancer\u003c\/p\u003e \u003cp\u003eSection 6: Diagnosis and Staging of Lung Cancer\u003c\/p\u003e \u003cp\u003e23. Diagnostic Work-Up of Suspected Lung Cancer\u003c\/p\u003e \u003cp\u003e24. Surgical Staging of the Mediastinum including Mediastinoscopy and Thoracoscopy, Preoperative and Intraoperative\u003c\/p\u003e \u003cp\u003e25. The 8th Edition of the Tumor, Node and Metastasis Classification of Lung Cancer\u003c\/p\u003e \u003cp\u003eSection 7: Surgical Management of Lung Cancer\u003c\/p\u003e \u003cp\u003e26. Preoperative Functional Evaluation of the Surgical Candidate\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27. Results of Video Assisted Techniques for Resection of Lung Cancer\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28. Results of Robotic Techniques for Resection of Lung Cancer\u003c\/p\u003e \u003cp\u003e29. Extent of Surgical Resection for Stage I and II Lung Cancer\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30. Extended Resections for Lung Cancer: Chest Wall and Pancoast Tumors\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31. Extended Resections for Lung Cancer: Broncho\/Vascular Sleeve Resections\u003c\/p\u003e \u003cp\u003e32. Multiple Nodules: Management of the Patient with Synchronous or Metachronous Lung Cancers\u003c\/p\u003e \u003cp\u003e33. Surgical Management of the Marginally Resectable Patient\u003c\/p\u003e \u003cp\u003eSection 8: Radiotherapeutic Management of Lung Cancer\u003c\/p\u003e \u003cp\u003e34. Technical Requirements for Lung Cancer Radiotherapy\u003c\/p\u003e \u003cp\u003e35. Radiobiology of Lung Cancer\u003c\/p\u003e \u003cp\u003e36. Patient Selection for Radiotherapy\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37. Stage I Non-Small Cell Lung Cancer and Oligometastatic Disease\u003c\/p\u003e \u003cp\u003e38. Ablation Options for Localized Lung Cancer\u003c\/p\u003e \u003cp\u003e39. Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer, including Combined Modality\u003c\/p\u003e \u003cp\u003e40. Radiotherapy in the Management of Small Cell Lung Cancer: Thoracic Radiotherapy, Prophylactic Cranial Irradiation\u003c\/p\u003e \u003cp\u003e41. Palliative Radiotherapy for Lung Cancer: Locoregional and Metastatic\u003c\/p\u003e \u003cp\u003e42. Acute and Late Toxicities of Thoracic Radiotherapy: Pulmonary, Esophagus, Heart\u003c\/p\u003e \u003cp\u003e43. Treatment-Related Neurotoxicity, Medical and Radiation Therapy\u003c\/p\u003e \u003cp\u003eSection 9: Chemotherapy and Targeted Agents for Lung Cancer\u003c\/p\u003e \u003cp\u003e44. Front-Line Systemic Options in Non-Small Cell Lung Cancer\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45. Systemic Options in Second Line and Beyond\u003c\/p\u003e \u003cp\u003e46. Maintenance Therapy in NSCLC\u003c\/p\u003e \u003cp\u003e47. Pharmacogenomics and Lung Cancer\u003c\/p\u003e \u003cp\u003e48. New Targetable Pathways in Lung Cancer\u003c\/p\u003e \u003cp\u003e49. Management of Toxicities of Targeted Therapies\u003c\/p\u003e \u003cp\u003e50. Immunotherapy and Lung Cancer\u003c\/p\u003e \u003cp\u003e51. Systemic Therapy in Early-Stage NSCLC \u003c\/p\u003e \u003cp\u003e52. Treatment of Small-Cell Lung Cancer\u003c\/p\u003e \u003cp\u003eSection 10: Other Thoracic Malignancies\u003c\/p\u003e \u003cp\u003e53. Malignant Mesothelioma \u003c\/p\u003e \u003cp\u003e54. Mediastinal Tumors\u003c\/p\u003e \u003cp\u003e55. Neuroendocrine Tumors of the Lung Other than SCLC\u003c\/p\u003e \u003cp\u003e56. Thymic Cancer\/Thymoma\u003c\/p\u003e \u003cp\u003eSection 11: Symptom Management and Complications\u003c\/p\u003e \u003cp\u003e57. Lung Cancer Emergencies\u003c\/p\u003e \u003cp\u003e58. Role of Palliative Care in Lung Cancer\u003c\/p\u003e \u003cp\u003eSection 12: Clinical Trials\u003c\/p\u003e \u003cp\u003e59. Methodology of Clinical Trials in Lung Cancer\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60. How to Promote and Organize Clinical Research in Lung Cancer\u003c\/p\u003e \u003cp\u003eSection 13: Thoracic Oncology Advocacy\u003c\/p\u003e \u003cp\u003e61. Role of Advocacy Groups in Lung Cancer\u003c\/p\u003e \u003cp\u003e62. Health Services Research in Lung Cancer\u003c\/p\u003e \u003cp\u003eAppendix\u003c\/p\u003e \u003cp\u003e63. Appendix: Diagnostic Algorithms\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46650448544024,"sku":"9780323523578","price":134.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323523578_b2c9754d-9580-4f54-8425-02c33004cd95.jpg?v=1694989899","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/iaslc-thoracic-oncology-hardback-9780323523578","provider":"Freshly Printed Books","version":"1.0","type":"link"}